High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

References

• Okonko DO, Van Veldhuisen DJ, Poole-Wilson PA, Anker SD. Anaemia of chronic disease in chronic heart failure: the emerging evidence. Editorial. Eur Heart J. 2005;26: 2213–4.
   PubMed Web of Science ®Google Scholar
• Sharma R, Francis DP, Pitt B, Poole-Wilson PA, Coats AJS, Anker SD. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J. 2004;25:1021–8.
   PubMed Web of Science ®Google Scholar
• Turner SJ, Ketch TR, Gandhi SK, Sane DC. Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes. Am Heart J. 2008;155: 806–16.
   PubMed Web of Science ®Google Scholar
• Kannel WB, Gordon T, Wolf PA, McNamara P. Hemoglobin and the risk of cerebral infarction: The Framingham Study. Stroke. 1972;3:409–20.
   PubMed Web of Science ®Google Scholar
• Campbell MJ, Elwood PC, Mackean J, Waters WE. Mortality, haemoglobin level and haematocrit in women. J Chron Dis. 1985;38:881–9.
   PubMedGoogle Scholar
• Abu-Zeid HAH, Chapman JM. The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study. J Chron Dis. 1976;29:395–403.
   PubMedGoogle Scholar
• Gagnon DR, Zhang T-J, Brand FN, Kannel WB. Hematocrit and the risk of cardiovascular disease—The Framingham Study: A 34-year follow-up. Am Heart J. 1994;127:674–82.
   PubMed Web of Science ®Google Scholar
• Sorlie PD, Garcia-Palmieri MR, Costas R Jr, Havlik RJ. Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J. 1981;101:456–61.
   PubMed Web of Science ®Google Scholar
• Kiyohara Y, Ueda K, Hasuo Y, Fujii I, Yanai T, Wada J, . Hematocrit as a risk factor of cerebral infarction: long-term prospective population survey in a Japanese rural community. Stroke. 1986;17:687–92.
   PubMed Web of Science ®Google Scholar
• Wilhelmsen L, Wedel H, Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973;48: 950–8.
   PubMed Web of Science ®Google Scholar
• Shimakawa T, Bild DE. Relationship between hemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol. 1993;46:1257–66.
   PubMed Web of Science ®Google Scholar
• Merono T, Sorroche P, Rosso LAG, Casanas L, Boero LE, Arbelbide JA, . Proatherogenic disturbances in lipoprotein profile, associated enzymes and transfer proteins in women with iron deficiency anaemia. Clin Biochem. 2010; 43:416–23.
   PubMed Web of Science ®Google Scholar
• Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, . Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol. 2004;44:547–53.
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Jungner I, Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2008;264:30–8.
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009; 265:275–87.
   PubMed Web of Science ®Google Scholar
• Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, . Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100:879–87.
   PubMed Web of Science ®Google Scholar
• Balla G, Jacob HS, Eaton JW, Belcher JD, Vercellotti GM. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb. 1991;11:1700–11.
   PubMedGoogle Scholar
• Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M, . Hemoglobin and its scavenger protein haptoglobin associate with apoA-1 containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem. 2009;284:18292–301.
   PubMed Web of Science ®Google Scholar
• Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, . Haptoglobin: basic and clinical aspects. Antioxid Redox Signal. 2010;12:293–304.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358:2026–33.
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009;266:558–70.
   PubMed Web of Science ®Google Scholar
• Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann Med. 2009;41:522–32.
   PubMed Web of Science ®Google Scholar
• Medin J, Nordlund A, Ekberg K. Increasing stroke incidence in Sweden between 1989 and 2000 among persons aged 30 to 65 years: evidence from the Swedish Hospital Discharge Register. Stroke. 2004;35:1047–51.
   PubMed Web of Science ®Google Scholar
• Hammar N, Alfredsson L, Rosén M, Spetz C-L, Kahan T, Ysberg A-S. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol. 2001;30 (Suppl 1):S30–4.
   PubMedGoogle Scholar
• Jungner I, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females. Int J Clin Lab Res. 1992;21:247–55.
   PubMedGoogle Scholar
• Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 values in 147 576 Swedish males and females, standardized according to the World Health Organization—International Federation of Clinical Chemistry First International Reference Materials. Clin Chem. 1998;44:1641–9.
   PubMed Web of Science ®Google Scholar
• Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol. 2002;22:1918–23.
   PubMed Web of Science ®Google Scholar
• Lowe GDO, Forbes CD. Blood rheology and thrombosis. Review. Clin Haematol. 1981;10:343–67.
   PubMedGoogle Scholar
• Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973;4:576–81.
   PubMed Web of Science ®Google Scholar
• Dormandy JA, Gutteridge JMC, Hoare E, Dormandy TL. Effect of clofibrate on blood viscosity in intermittent claudication. Br Med J. 1974;4:259–62.
   PubMed Web of Science ®Google Scholar
• Dormandy JA, Hoare E, Khattab AH, Arrowsmith DE, Dormandy TL. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J. 1973;4:581–3.
   PubMed Web of Science ®Google Scholar
• Thomas DJ, Marshall J, Russell RW, Wetherley-Mein G, du Boulay GH, Pearson TC, . Effect of haematocrit on cerebral blood-flow in man. Lancet. 1977;2:941–3.
   PubMed Web of Science ®Google Scholar
• Wood JH, Kee DB Jr. Hemorheology of the cerebral circulation in stroke. Progress Review. Stroke. 1985;16:765–72.
   PubMed Web of Science ®Google Scholar
• Müller R, Lehrach F. Haemorheology and cerebrovascular disease: multifunctional approach with pentoxifylline. Curr Med Res Opin. 1981;7:253–63.
   PubMed Web of Science ®Google Scholar
• Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, Galajda Z, . Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol. 2010;30:1347–53.
   PubMed Web of Science ®Google Scholar
• Paterson JC. Vascularization and hemorrhage of the intima of arteriosclerotic coronary arteries. Arch Pathol. 1936; 22:313–24.
   Google Scholar
• Barger AC, Beeuwkes R III, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310:175–7.
   PubMed Web of Science ®Google Scholar
• Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of combined phase I and II clinical trial. N Engl J Med. 1987; 316:73–8.
   PubMed Web of Science ®Google Scholar
• Tsakiris D. Morbidity and mortality reduction associated with the use of erythropoietin. Nephron. 2000;85 (Suppl 1): 2–8.
   PubMedGoogle Scholar
• Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, . Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355:2071–84.
   PubMed Web of Science ®Google Scholar
• Voors AA, Belonje AMS, Zijlstra F, Hillege HL, Anker SD, Slart RHJA, . A single dose of erythropoietin in ST-elevation myocardial infarction. Eur Heart J. 2010;31: 2593–600.
   PubMed Web of Science ®Google Scholar
• Kümler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Köber L, . Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008;10:658–60.
   PubMed Web of Science ®Google Scholar